Acute lung injury in children--kids really aren't just "little adults"

Neal J Thomas1, Philippe Jouvet, Douglas Willson

  • 1Division of Pediatric Critical Care Medicine, Department of Pediatrics, Pennsylvania State University College of Medicine, Penn State Hershey Children's Hospital, Hershey, PA, USA. nthomas@hmc.psu.edu

Insights

Experts will convene to establish a consensus on pediatric acute lung injury (ALI) definitions, treatments, and outcomes. This aims to improve care and guide future research for better patient outcomes in pediatric ALI.

Area of Science:

  • Pediatric critical care medicine
  • Respiratory medicine
  • Lung injury research

Background:

  • Pediatric acute lung injury (ALI) remains a significant challenge with high morbidity and mortality.
  • Current understanding of pediatric ALI is limited despite extensive research.
  • There is a need for standardized definitions and treatment protocols.

Purpose of the Study:

  • To outline the objectives and methods of the Pediatric Acute Lung Injury Consensus Conference.
  • To develop a refined taxonomy for defining pediatric ALI, including predisposing factors, etiology, and pathophysiology.
  • To foster expert consensus on key aspects of pediatric ALI management and outcomes.

Main Methods:

  • A one-year consensus conference involving 26 pediatric acute lung injury experts.
  • Utilizing a modified Delphi approach to achieve strong professional agreement.
  • Systematic review and discussion of critical pediatric ALI topics.

Main Results:

  • The conference will focus on achieving consensus in nine critical areas of pediatric ALI.
  • These areas include definition, epidemiology, comorbidities, severity, ventilatory support, ancillary treatments, monitoring, noninvasive and extracorporeal support, and long-term outcomes.
  • The goal is to establish a unified framework for pediatric ALI.

Conclusions:

  • This consensus effort is crucial for advancing the care and research of pediatric ALI.
  • Standardizing knowledge and expertise will provide a framework for future progress.
  • Improving the understanding and management of pediatric ALI is essential to reduce patient morbidity and mortality.
Abstract

Related Concept Videos

Pulmonary Cycle: Exhalation01:17

Pulmonary Cycle: Exhalation

In terms of human respiration, the act of expelling air, known as exhalation (or expiration), operates on the principle of pressure gradients. During expiration, the pressure within the lungs exceeds that of the surrounding atmosphere. Under normal conditions, quiet breathing involves passive exhalation and is free of muscular contractions. This is because the exhalation process is driven by the natural elastic recoil of the lungs and chest wall, both of which have an inherent tendency to...
Pneumonia I: Introduction01:30

Pneumonia I: Introduction

Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...